
RNA-targeting strategy successfully blocks a vexing driver of Parkinson's disease A new drug-like compound prevents the body from producing a protein thats often at the root of Parkinsons.
December 30, 2020
JUPITER, FLA Scientists at Scripps Research have developed a drug-like compound that selectively prevents production of the protein underlying most causes of Parkinson's disease, alpha-synuclein.
The study underscores the untapped potential of addressing diseases mediated by undruggable proteins via the messenger RNAs that encode them.
To be published the week of Dec. 30 in the Proceedings of the National Academies of Sciences, the study is authored by Scripps Research chemistry professor Matthew D. Disney, PhD, and graduate student Peiyuan Zhang, and their colleagues.
If DNA serves as the code of life, genes within DNA provide the code for specific proteins. For a gene to actually encode a protein, however, it must first be transcribed with the help of messenger RNA. The messenger RNA serves as a template for protein production, a process called translation, which is orchestrated by molecular machines called ribosomes.
Disney's alpha-synuclein compound, which he named synucleozid, stops the ribosome from detecting the messenger RNA template, thus preventing the translation or printing of the alpha-synuclein protein. The Scripps Research team collaborated on the study with a team from Rutgers University led by M. Maral Mouradian, MD, director of the Institute for Neurological Therapeutics.
We showed not only that we can inhibit the translation of alpha-synuclein, which is an important protein in Parkinson's disease and dementia, but also that this compound can stop its messenger RNA from being recognized by a ribosome, Disney says. In other words, the compound doesn't allow the messenger RNA to be made into the alpha-synuclein protein. We believe this unique mechanism is broadly applicable.
Disney has spent more than a decade building technologies capable of identifying drug-like compounds to do this. A system he invented called Inforna computationally uses genetic sequence to predict complementary small molecule-RNA interactions.
Most drugs on the market work by binding to problematic proteins to limit their ability to cause harm. However, for a drug to bind, those proteins must have stable structures with favorable binding pockets.
The alpha-synuclein protein is one example of many in the genome that have confounded scientists' efforts to bind with medications, due to their undefined structure.
In fact, the so-called druggable genome is currently comprised of only about 3,000 genes out of an estimated 20,000 protein-coding genes. Disney says his research suggests that many undruggable proteins are transcribed by RNA that do have stable structures, meaning the RNA should be druggable, offering an effective workaround.
We are applying this across a number of disease indications, with our priority being applying these approaches to the diseases that have the most urgent medical need, Disney says.
Parkinson's disease is clearly among them. With an estimated 1 million people in the United States alone living with the condition, at an estimated cost of over $50 billion annually, Parkinson's causes chronic, progressive disability due to the death of dopamine-producing cells in the brain. The symptoms may include slowness of movements, impaired coordination, limb and trunk stiffness, tremor, and eventually dementia and psychiatric manifestations.
Symptoms emerge as the alpha-synuclein protein accumulates in brain cells, misfolding and aggregating to form clumps called Lewy bodies and Lewy neurites. Certain forms of these aggregates are toxic and eventually lead to the cell's death.
Mouradian says down-regulating production of alpha-synuclein may have therapeutic promise.
The precise molecular mechanisms driving Parkinson's disease remain to be fully elucidated. However, the amount of alpha-synuclein protein levels is an important factor in its pathologic misfolding and aggregation, initiating a cascade of events that lead to neuronal damage and Parkinson's symptoms, Mouradian says. Therefore, it stands to reason that reducing the amount of alpha-synuclein protein can mitigate this disease-causing cascade, and slow down or stop disease progression. Identification of this alpha-synuclein messenger RNA-targeting probe will enable us to evaluate the therapeutic value of reducing alpha-synuclein production in patients.
Many people with Parkinson's respond for a time to therapeutics that include dopamine replacement. But adding back dopamine doesn't protect the nervous system from the progressively worsening disease process, and introduces its own set of sometimes serious side-effects.
We wanted to see if we could inhibit this protein from even being made by targeting the messenger RNA that encodes it, Disney says.
The benefit of choosing a small molecule to do this rather than an RNA-binding oligonucleotide is that a therapeutic agent must be very, very small to cross the blood-brain barrier. It must also be selective, and apparently these starting compounds are selective.
We found the molecule was very selective at the RNA level. We also studied the effects at the protein level, and the molecule was also selective on that level, Disney says.
But Disney notes that this is a proof-of-concept study, and that a long road lies ahead before Synucleozid might become a Parkinson's drug candidate that can move into clinical trials in humans.
We are just at the beginning here, and there is much work to do Disney says. We are showing that if you can inhibit a protein from being made, that may be advantageous over waiting to address its role in disease until after it is already made.
The study, Trans
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
16/11/2026
November 16, 2026
Hitachi system enables proton beams to be delivered from 360 degrees around the patient, expanding treatment capacity and supporting more pre...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Hiltron Communications has received a repeat order from one of Europes longest established communications satellite operators. Central to this project is a Hilt...
16/11/2026
Fabric Insights and Fonn Group today announce a partnership to connect editorial planning and media operations across their complementary product portfolios.
...
16/11/2026
Density 1.0 brings a complete color grading workflow to Final Cut Pro
Brie Clayton November 16, 2026
0 Comments
Filmmaker Pascal Basel's plugin pr...
16/11/2026
Berklee Students to Perform at Boston's CITGO Sign Relighting Kuper Walker, Ollie Mann, and dreamcorp. will perform at the free public celebration in Kenm...
16/11/2026
The Hollywood Reporter Names Berklee Among World's Best Music Schools The annual list spotlights Berklee's screen scoring programs and new master'...
16/11/2026
Five years ago, Lightware launched the original Taurus UCX with a clear vision: USB-C would become the central connection in meeting rooms. The goal was simple:...
16/11/2026
Sonniss: bundles over 80% below their libraries' prices, plus up to 60% off ...
16/11/2026
Singaporean Comedy Luck My Life Shot with Blackmagic URSA Cine 17K 65
Brie Clayton November 16, 2026
0 Comments
Blackmagic PYXIS 12K and DaVinci Resol...
16/11/2026
As countries gather to discuss climate targets at COP 31 this week, one question that is at the heart of debates is how to measure the environmental impact of t...
16/11/2026
Announced today at SC26, NVIDIA Rubin HPC is a new GPU in the NVIDIA Vera Rubin ...
16/11/2026
This week at SC26, NVIDIA is marking two decades of CUDA by honoring the researchers, developers and engineers who helped make GPU computing a foundation for mo...
16/11/2026
With expanded NVIDIA CUDA-X libraries, including cuPhoton, cuPotential and cuSpa, researchers can sift through vast amounts of data to accelerate research, from...
16/11/2026
In its MLPerf benchmarks debut, with results released today, the NVIDIA Vera Rub...
16/11/2026
Quantum processor deployments at supercomputing centers have grown nearly sevenfold over the past five years, with nearly 30 supercomputing centers around the w...
16/11/2026
To train an AI model, thousands of GPUs have to work together, requiring a network that's fast, efficient and resilient.
Lambda is tackling the network pie...
15/11/2026
Mixers, interfaces & DAW controller receive new firmware
Yamaha have just launched a trio of firmware updates that bring some powerful new functionality to ...
15/11/2026
Can VideoProc AI Really Reduce Noise and Enhance Blurry, Old Footage? Real-World...
15/11/2026
Over two days at COEX, more than 2,000 attendees converged for AI Day Seoul, bri...
14/11/2026
Longtime MLB Network employee David Maybrown passed away Thursday at the age of 57. David joined MLB Network in 2009 shortly after its launch, beginning as an i...
14/11/2026
Modular innovators introduce two guitar-based products
ADDAC System's recently introduced Four String Series makes it possible to integrate physical str...
14/11/2026
Marcelo Dai's Live Session Captured with URSA Cine Immersive
Brie Clayton November 14, 2026
0 Comments
Artist takes viewers on an immersive journe...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Newest Lenses, Horizon Anamorphic Seminar & Guided Lens Character Experience Highlight Creative Possibilities
At the 2026 Toru CAMERIMAGE Film Festival, ZEISS...
14/11/2026
Sonnet Announces Black Friday Sale on Select Products
Brie Clayton November 14, 2026
0 Comments
WHAT: Sonnet Technologies is having a sale on a select...
14/11/2026
Berklee Alumni Shine at the 2026 Latin Grammy Awards This year's winners included songwriters, engineers, and performers who contributed to acclaimed reco...
13/11/2026
The UIM E1 Series wraps its third season this week with the Bombay Sapphire E1 Miami GP, Nov. 11-14, on Biscayne Bay at the Miami Seaplane Base on Watson Island...
13/11/2026
In-venue and creative video staffers at the professional and collegiate level ha...
13/11/2026
Singer-songwriter Benson Boone will headline entertainment for the Discover NHL Winter Classic between the Utah Mammoth and Colorado Avalanche at Rice-Eccles St...
13/11/2026
Blackmagic Design has announced the Blackmagic Ambisonic Microphone, a 7th order ambisonic microphone array that captures spatial audio for immersive video prod...
13/11/2026
SMPTE has announced that The Studio B&H and Riedel Communications will provide the video infrastructure and communications technology for the Solutions Hub at t...
13/11/2026
The Hollywood Professional Association (HPA) has announced the theme and program focus for the 2027 HPA Tech Retreat, which takes place Feb. 14-18, 2027, in La ...
13/11/2026
Football Manager 27 Touch is available on Apple Arcade starting today. The game ...
13/11/2026
MotoGP has announced a two-year media rights agreement with ESPN covering the Un...
13/11/2026
Apple Sports, the free iPhone app, has added the Ultimate Fighting Championship (UFC) to its lineup of supported sports, in time for Saturday's UFC 334. The...
13/11/2026
The NBA and Fanatics Studios, the joint venture between Fanatics and entertainme...
13/11/2026
ESPN held its annual EDGE Innovation Conference last night and offered up an ove...
13/11/2026
Regional sports network gives Ithaca College, SUNY Cortland students a platform to thrive
One of the biggest games in Division III college football will be pla...
13/11/2026
Studer-inspired 500-series PWM compressor unveiled
The HLabs range already includes a couple of Studer-inspired offerings in the form of the PRE169 and EQ16...